Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
ΔCS-PP
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/02/2021
S-Trimer
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/01/2021
ΔABP-α2
Potential treatment - theoretical effect Experimental Antiviral Mar/01/2021
W4P-RBD
Potential treatment - pre-clinical evidence Experimental Vaccine Feb/26/2021
1212C2
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021
VS12
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021
VS10
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021
Genz-667161
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021
Genz-123346
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021
J08-MUT
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/23/2021
Ethaselen
Potential treatment - theoretical effect Experimental Antiviral Feb/23/2021
rSIFN-co
Potential treatment - clinical evidence Experimental Antiviral Feb/23/2021
Imiglitazar
Potential treatment - theoretical effect Experimental Antiviral Feb/23/2021
Salvianolic acid A
Potential treatment - theoretical effect Experimental Antiviral Feb/23/2021
PF-03715455
Potential treatment - theoretical effect Experimental Antiviral Feb/23/2021
2-{3-[3-Chloro-5-(cyclopropylmethoxy)phenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}benzonitrile
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/22/2021
C1632
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/22/2021
11-(1,3-Benzodioxol-5-yl)-5-bromo-8,9-dihydro-[1,3]benzodioxolo[7,6-g]phthalazine-7,10-dione
Potential treatment - theoretical effect Experimental Antiviral Feb/22/2021
(4Ar,5R,6aS,6aR,6bR,8aS,11R,14aR,14bR)-5-hydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,11,14b-heptamethyl-2,4a,5,6,6a,7,8,9,10,13,14,14a-dodecahydro-1H-picen-3-one
Potential treatment - theoretical effect Experimental Antiviral Feb/22/2021
5-(3,4-Dimethoxyphenyl)-2-methyl-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-5,7-dihydro-[1,3]thiazolo[3,2-a]pyrimidine-3,6-dione
Potential treatment - theoretical effect Experimental Antiviral Feb/22/2021